Navellier & Associates’s CME Group CME Stock Holding History
Bought
Maintained
Sold
Other funds holding CME
Navellier & Associates's CME Position: Q3 2026 in Review
Navellier & Associates reduced its CME Group (CME) stake by 3% in Q3 2026, selling an estimated $75.9K and leaving 9,474 shares worth $2.48M. The position accounts for 0.21% of the portfolio, ranked #118.
Navellier & Associates first reported a position in CME in Q2 2018 and has held it in 11 quarters since. The position peaked at $3.75M in Q3 2018. 1,763 funds tracked by Wall St. Rank hold CME as of Q3 2026.
- Navellier & Associates held 9,474 shares of CME Group worth $2.48M as of Q3 2026.
- Navellier & Associates sold 288 CME Group shares in Q3 2026, an estimated $75.9K.
- CME Group made up 0.21% of Navellier & Associates's portfolio in Q3 2026, its #118 holding.
- Navellier & Associates first reported a position in CME Group in Q2 2018 and has held it in 11 quarters since.
- Navellier & Associates's CME Group position peaked at $3.75M in Q3 2018.
- 1,763 funds tracked by Wall St. Rank held CME Group as of Q3 2026.
Based on Navellier & Associates's 13F filing for Q3 2026, filed 12 Nov 2026.